The Supreme Court sided with the maker of Roundup weedkiller in a ruling expected to block thousands of lawsuits alleging it ...

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — The chair of the ...

A clinical trial testing two drugs against the Bundibugyo ebolavirus, which is driving a fast-moving outbreak in Central ...

At BIO 2026, executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug ...

The Tarasoff case remains a pivotal marker in bioethics at the bicentennial as we now reach the country’s 250th birthday.

Women are fully capable of making difficult decisions, but meaningful choice requires trusted, vetted information,” writes ...

RIP Sangamo, onshoring with drug manufacturing, and more biotech news from The Readout ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42. WASHINGTON — ...

Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...

A judge temporarily blocked federal prosecutors in Texas from getting access to the medical records of transgender patients ...